An employee removes vials of Covishield, the local name for the Covid-19 vaccine developed by AstraZeneca Plc at the Serum Institute of India Ltd. in Pune, Maharashtra, India. (Photographer: Dhiraj Singh/Bloomberg)
BQ Blue’s special research section collates quality and in-depth equity and economy research reports from across India’s top brokerages, asset managers and research agencies. These reports offer BloombergQuint’s subscribers an opportunity to expand their understanding of companies, sectors and the economy.